SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern.
Hojo-Souza NS, de Castro JT, Rivelli GG, Azevedo PO, Oliveira ER, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis B, Lourenço KL, Gomes IP, Assis BRD, Piccin M, Fonseca FG, Durigon E, Silva JS, de Souza RP, Goulart GAC, Santiago H, Fernandes APS, Teixeira SR, Gazzinelli RT.
Hojo-Souza NS, et al. Among authors: assis brd.
Vaccine. 2024 Oct 4;42(26):126394. doi: 10.1016/j.vaccine.2024.126394. Online ahead of print.
Vaccine. 2024.
PMID: 39368129
Free article.